Insider Transactions in Q1 2022 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 18
2022
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,940
-1.84%
|
$109,400
$10.0 P/Share
|
Mar 18
2022
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,940
+1.8%
|
$32,820
$3.53 P/Share
|
Mar 15
2022
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
104,603
+13.17%
|
-
|
Mar 04
2022
|
Glenn Sblendorio |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+20.26%
|
$60,000
$4.79 P/Share
|
Jan 18
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
8,564
-0.87%
|
$85,640
$10.23 P/Share
|
Jan 14
2022
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
32,386
-5.25%
|
$323,860
$10.53 P/Share
|
Jan 14
2022
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
63,317
+9.3%
|
-
|
Jan 14
2022
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,843
-5.11%
|
$188,430
$10.53 P/Share
|
Jan 14
2022
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,840
+9.08%
|
-
|
Jan 14
2022
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
58,891
-5.64%
|
$588,910
$10.53 P/Share
|
Jan 14
2022
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
388,759
+16.82%
|
-
|
Jan 14
2022
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,898
-5.11%
|
$168,980
$10.53 P/Share
|
Jan 14
2022
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,143
+10.58%
|
-
|
Jan 14
2022
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,684
-5.3%
|
$126,840
$10.53 P/Share
|
Jan 14
2022
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
91,306
+17.02%
|
-
|
Jan 05
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
63,543
-8.84%
|
$762,516
$12.18 P/Share
|
Jan 04
2022
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,368
-1.31%
|
$88,416
$12.48 P/Share
|
Jan 04
2022
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,041
-1.2%
|
$48,492
$12.48 P/Share
|
Jan 04
2022
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,575
-1.21%
|
$42,900
$12.48 P/Share
|
Jan 04
2022
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
11,336
-1.55%
|
$136,032
$12.48 P/Share
|
Jan 04
2022
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,692
-1.78%
|
$32,304
$12.48 P/Share
|
Jan 03
2022
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
154,711
+21.6%
|
-
|
Jan 03
2022
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
5,470
-1.33%
|
$60,170
$11.86 P/Share
|
Jan 03
2022
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,470
+1.31%
|
$16,410
$3.53 P/Share
|
Jan 03
2022
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,984
-1.21%
|
$59,808
$12.11 P/Share
|
Jan 03
2022
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,136
+17.88%
|
-
|
Jan 03
2022
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,538
-0.58%
|
$18,456
$12.11 P/Share
|
Jan 03
2022
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,136
+19.85%
|
-
|
Jan 03
2022
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,970
-1.32%
|
$35,640
$12.11 P/Share
|
Jan 03
2022
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
40,069
-5.2%
|
$480,828
$12.11 P/Share
|
Jan 02
2022
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,946
-6.36%
|
$307,406
$11.55 P/Share
|
Jan 02
2022
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,778
-5.63%
|
$173,558
$11.55 P/Share
|
Jan 02
2022
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,589
-2.84%
|
$72,479
$11.55 P/Share
|
Jan 02
2022
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
22,968
-2.9%
|
$252,648
$11.55 P/Share
|
Jan 02
2022
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,665
-6.6%
|
$117,315
$11.55 P/Share
|